Cargando…

The effects of ART on the dynamics of lipid profiles in Chinese Han HIV-infected patients: comparison between NRTI/NNRTI and NRTI/INSTI

INTRODUCTION: This article aimed to compare the prevalence of dyslipidemia and determine risk factors associated with lipid levels in a cohort of HIV-infected patients receiving two different antiretroviral therapy (ART) regimens, nucleoside reverse transcriptase inhibitor/non-nucleoside reverse tra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Shengnan, Wei, Baozhu, Liang, Wei, Chen, Tielong, Deng, Liping, Zhao, Min, Wan, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Public Health
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10174832/ https://www.ncbi.nlm.nih.gov/pubmed/37181701 http://dx.doi.org/10.3389/fpubh.2023.1161503

Ejemplares similares

Cost-effectiveness of 2NRTI+NNRTI versus 2NRTI+PI as the initial cART regimen
por: Aragão, F, et al.
Publicado: (2010)

633. Nanopore Sequencing and In-house Bioinformatic Pipeline for Rapid and Accurate Detection of NRTI, NNRTI, PI, and INSTI Drug Resistance Mutations
por: Salvaña, Edsel Maurice, et al.
Publicado: (2023)

High Prevalence of NRTI and NNRTI Drug Resistance Among ART-Experienced, Hospitalized Inpatients
por: Bossard, Claire, et al.
Publicado: (2021)

Effect on HIV-1 viral replication capacity of DTG-resistance mutations in NRTI/NNRTI resistant viruses
por: Pham, Hanh T., et al.
Publicado: (2016)

2508. Virologic Suppression in Patients Switched to BIC/TAF/FTC with Baseline NRTI and/or INSTI Resistance
por: Natali, Kayla M, et al.
Publicado: (2019)

Long-term CD4+ T-cell count evolution after switching from regimens including HIV nucleoside reverse transcriptase inhibitors (NRTI) plus protease inhibitors to regimens containing NRTI plus non-NRTI or only NRTI
por: Torti, Carlo, et al.
Publicado: (2011)

Long-term treatment outcomes of ritonavir-boosted lopinavir monotherapy among HIV-infected patients who experienced NRTI and NNRTI failure
por: Manosuthi, Weerawat, et al.
Publicado: (2012)

Treatment outcomes and plasma level of ritonavir-boosted lopinavir monotherapy among HIV-infected patients who had NRTI and NNRTI failure
por: Manosuthi, Weerawat, et al.
Publicado: (2009)

The state of PI monotherapy and NRTI-sparing therapy
por: Arribas, JR
Publicado: (2010)

HTA and HIV: The Case of Dual NRTI Backbones in the Italian Setting
por: Garagiola, Elisabetta, et al.
Publicado: (2020)

Machine learning aided multiscale modelling of the HIV-1 infection in the presence of NRTI therapy
por: Tunc, Huseyin, et al.
Publicado: (2023)

Disease Management - Constructing Optimal NRTI-Based Combinations: Past, Present, and Future
por: Dieterich, Douglas T
Publicado: (2006)

Lopinavir/r + Efavirenz combination as a potent NRTI sparing antiretroviral therapy
por: Henrivaux, Philippe, et al.
Publicado: (2010)

Improvement of endothelial function after switching previously treated HIV-infected patients to an NRTI-sparing bitherapy with maraviroc
por: Bernal, Enrique, et al.
Publicado: (2014)

High level of HIV drug resistance informs dolutegravir roll-out and optimized NRTI backbone strategy in Mozambique
por: Carnimeo, V, et al.
Publicado: (2021)

Beyond the polymerase-γ theory: Production of ROS as a mode of NRTI-induced mitochondrial toxicity
por: Smith, Reuben L., et al.
Publicado: (2017)

HIV-1 Resistance to Islatravir/Tenofovir Combination Therapy in Wild-Type or NRTI-Resistant Strains of Diverse HIV-1 Subtypes
por: Cilento, Maria E., et al.
Publicado: (2023)

Conservation Patterns of HIV-1 RT Connection and RNase H Domains: Identification of New Mutations in NRTI-Treated Patients
por: Santos, André F. A., et al.
Publicado: (2008)

Impact of NRTI backbone on renal, bone and cardiovascular markers in HIV-infected individuals receiving a boosted protease inhibitor
por: Barber, Tristan, et al.
Publicado: (2014)

Increased CD127+ and decreased CD57+ T cell expression levels in HIV-infected patients on NRTI-sparing regimens
por: Gonzalez-Serna, A., et al.
Publicado: (2017)

An observational comparison of first-line combination antiretroviral treatment (cART) with 2NRTI and ATV/r or DRV/r in HIV-infected patients in Italy
por: Cozzi-Lepri, Alessandro, et al.
Publicado: (2014)

Treatment Switch to Dolutegravir With 2 Nucleoside Reverse-Transcriptase Inhibitors (NRTI) in Comparison to Continuation With Protease Inhibitor/Ritonavir Among Patients With Human Immunodeficiency Virus at Risk for Prior NRTI Resistance: A Cohort Analysis of Real-World Data
por: Sangaré, Mohamed N’dongo, et al.
Publicado: (2020)

Efficacy and safety of an NRTI-sparing regimen in antiretroviral-naïve HIV-infected patients: once-daily maraviroc plus lopinavir/ritonavir
por: Nozza, S, et al.
Publicado: (2010)

Polymorphisms in DNA polymerase γ affect the mtDNA stability and the NRTI-induced mitochondrial toxicity in Saccharomyces cerevisiae
por: Baruffini, Enrico, et al.
Publicado: (2015)

DRV concentrations and viral load in CSF in patients on DRV/r 600/100 or 800/100mg once daily plus two NRTI
por: Di Yacovo, Silvana, et al.
Publicado: (2014)

Liver fibrosis progression and clinical outcomes are intertwined: role of CD4+ T-cell count and NRTI exposure from a large cohort of HIV/HCV-coinfected patients with detectable HCV-RNA: A MASTER cohort study
por: Focà, Emanuele, et al.
Publicado: (2016)

2492. Differences between Individuals Currently Taking Integrase Inhibitor (INSTI)-based Therapy and Those Not Taking INSTIs in the Era of INSTIs as Recommended First-line Therapy
por: Monroe, Anne K, et al.
Publicado: (2019)

Association Between ABCA1 Gene Polymorphisms and the Risk of Hypertension in the Chinese Han Population
por: Ren, Yanli, et al.
Publicado: (2022)

Effects of CYP3A4 Polymorphisms on Drug Addiction Risk Among the Chinese Han Population
por: Wang, Li, et al.
Publicado: (2019)

Prevalence of Human Papillomavirus Among Chinese Han and Mongols Minority Women in Inner Mongolia, China: Reflected by Self-Collected Samples in CHIMUST
por: Guo, Chunlei, et al.
Publicado: (2022)

Risk Prediction for Non-alcoholic Fatty Liver Disease Based on Biochemical and Dietary Variables in a Chinese Han Population
por: Pan, Xinting, et al.
Publicado: (2020)

Dolutegravir, the Second-Generation of Integrase Strand Transfer Inhibitors (INSTIs) for the Treatment of HIV
por: Dow, Dorothy E., et al.
Publicado: (2014)

Serum Lipid Profiles and All-Cause Mortality: A Retrospective Single Center Study on Chinese Inpatient Centenarians
por: Zou, Xiao, et al.
Publicado: (2022)

Selected CNS Outcomes Among INSTI Antiretrovirals
por: Wohl, David, et al.
Publicado: (2017)

The Emergence of Resistance Under Firstline INSTI Regimens
por: Xie, Zhiman, et al.
Publicado: (2022)

Performance and usability evaluation of the INSTI HIV self-test in Kenya for qualitative detection of antibodies to HIV
por: Bwana, Priska, et al.
Publicado: (2018)

Safety and efficacy of pharmacotherapy containing INSTIs and chemotherapy drugs in people living with HIV and concomitant colorectal cancer
por: Yang, Jing, et al.
Publicado: (2022)

Association between white blood cell count and non-alcoholic fatty liver disease in urban Han Chinese: a prospective cohort study
por: Wang, Shukang, et al.
Publicado: (2016)

The Impact of Pandemics Sentiment on the Global Art Market
por: Wang, Wei
Publicado: (2021)

Circulating (1 → 3)-β-D-Glucan as an immune activation marker decreased after ART in people living with HIV
por: Xun, Jingna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lbfgraefl0s4h1ino4pim17mk1